[Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases].
Fabregas-Canales
D
D
Clinique de Rhumatologie, Hôpital Lariboisière, Paris.
Meyer
O
O
Haim
T
T
Kuntz
D
D
D000906:Antibodies / Q000032:analysis*; D001172:Arthritis, Rheumatoid / Q000276:immunology; D002908:Chronic Disease; D006801:Humans; D007381:Intermediate Filament Proteins / Q000276:immunology*; D007633:Keratins / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D012216:Rheumatic Diseases / Q000276:immunology*; D012595:Scleroderma, Systemic / Q000276:immunology; D012859:Sjogren's Syndrome / Q000276:immunology; D013167:Spondylitis, Ankylosing / Q000276:immunology; D014746:Vimentin / Q000276:immunology
D000906:Antibodies; D007381:Intermediate Filament Proteins; D014746:Vimentin; D007633:Keratins
Signification des anticorps anti-filaments intermédiaires au cours de la polyarthrite rhumatoïde, des rhumatismes inflammatoires chroniques et des connectivites.